Pharma & Biotech
-
GSK Bets $10.6 Billion on Lung Cancer – and Its Montco Footprint Grows With It
GSK is making its largest acquisition in more than a decade, and Montgomery County has a clear stake in what comes next, writes John George for The Philadelphia Business Journal. The London-based pharmaceutical giant, which has major research and manufacturing operations in Upper Providence and Upper Merion, has agreed to acquire Boston-based Nuvalent for $10.6…
-
Wynnewood’s StromaGenesis Is Using Breakthrough AI to Revolutionize How Cancer Is Detected
A Wynnewood biotech company founded by one of the region’s most accomplished cancer researchers is betting that artificial intelligence could transform how cancer is detected and treated, writes John George for The Philadelphia Business Journal. A New Kind of Cancer Diagnostics Company StromaGenesis, founded by physician-scientist Dr. Richard Pestell, is seeking to raise $10 million…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
